R. Murdock - Jun 13, 2022 Form 3 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
General Counsel
Signature
/s/ Hunter Murdock
Stock symbol
AXSM
Transactions as of
Jun 13, 2022
Transactions value $
$0
Form type
3
Date filed
6/15/2022, 04:31 PM
Next filing
Mar 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AXSM Stock Option (Right to Buy) Jun 13, 2022 Common Stock 40K $32.55 Direct F1
holding AXSM Stock Option (Right to Buy) Jun 13, 2022 Common Stock 52.4K $29.91 Direct F2
holding AXSM Restricted Stock Units Jun 13, 2022 Common Stock 22.3K Direct F3, F4
holding AXSM Restricted Stock Units Jun 13, 2022 Common Stock 27.7K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on December 13, 2021. 25% of the option vests on the one (1) year anniversary of the date of grant with the remaining 75% to vest in equal increments on a quarterly basis over a four (4) year period, until fully vested.
F2 The option was granted on March 4, 2022, and vests in equal increments on a quarterly basis over a four (4) year period, until fully vested.
F3 The restricted stock units ("RSUs") were granted on December 13, 2021. 25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in three substantially equal annual installments, such that the RSUs will be fully vested on December 13, 2025. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the "Plan")), (ii) separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability) of the reporting person or (iii) seven (7) years from the date of grant.
F4 Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F5 The RSUs were granted on March 4, 2022. 25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in three substantially equal annual installments, such that the RSUs will be fully vested on March 4, 2026. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Plan), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant.